公众号 / 文章呼吸衰竭与机械通气重症综合管理与镇静镇痛

COVID-19患者自发性咯血

Spontaneous Hemoptysis in a Patient With COVID-19.
PubMed 文献 · Chest · 2021-01-01
一句话结论COVID-19重症患者恢复期可突发大咯血需再插管和升压,提示气道出血是延迟并发症。

本文报告一例65岁男性COVID-19患者,有高血压、糖尿病、慢性肾病、病态肥胖、阵发性房颤和吸烟史。初始表现为呼吸困难、干咳、咽痛和腹泻,鼻咽拭子SARS-CoV-2阳性。给予头孢曲松、多西环素、羟氯喹和甲泼尼龙1 mg/kg IV 3天。第3天需气管插管、血管升压药和连续肾脏替代治疗。第10天WBC升至28 K/cumm,呼吸道培养出铜绿假单胞菌,予IV美罗培南。第20天停升压药并拔管。第23天发生显著咯血,需再插管和升压药支持。

要点

  • 65岁男性COVID-19患者,有慢性肾病、病态肥胖、房颤和吸烟史,初始鼻咽拭子SARS-CoV-2阳性。
  • 第3天需气管插管、血管升压药和连续肾脏替代治疗,提示重症进展。
  • 第10天WBC升至28 K/cumm,呼吸道培养出铜绿假单胞菌,开始IV美罗培南治疗。
  • 第23天发生显著咯血,需再插管和血管升压药支持,提示恢复期气道出血风险。

适用人群与场景

  • 65岁男性COVID-19患者,有高血压、糖尿病、慢性肾病、病态肥胖、阵发性房颤和吸烟史,初始表现为呼吸困难、干咳、咽痛和腹泻。

诊断标准与关键阈值

  • 鼻咽拭子SARS-CoV-2阳性确诊COVID-19;胸部X线示双侧肺 opacity 提示多灶性肺炎。

处置流程与药物剂量

  • 初始予头孢曲松、多西环素、羟氯喹和甲泼尼龙1 mg/kg IV 3天。
  • 第3天因病情需要气管插管、血管升压药支持和连续肾脏替代治疗。
  • 血培养阴性、呼吸道培养仅正常口腔菌群后停用抗生素。
  • 第10天WBC升至28 K/cumm,呼吸道培养出铜绿假单胞菌,开始IV美罗培南。
  • 第20天停血管升压药并拔管;第23天因显著咯血再插管和升压药支持。

红旗征与不能漏的情况

  • 第23天发生显著咯血,需再插管和血管升压药支持,提示大咯血致气道阻塞或休克风险。

研究设计与关键结果

  • 个案报道:65岁男性COVID-19患者,初始予头孢曲松、多西环素、羟氯喹和甲泼尼龙1 mg/kg IV 3天,第3天需插管、升压药和CRRT,第10天培养出铜绿假单胞菌予美罗培南,第20天拔管,第23天显著咯血需再插管和升压药。

证据类型、等级与局限

  • 病例报告,证据等级低,仅描述单例病程,不能推断因果关系或通用推荐。

对床旁实践的改变

  • COVID-19重症患者恢复期仍需警惕突发大咯血,可能需紧急再插管和血流动力学支持。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

A 65-year-old man presented with shortness of breath, gradually worsening for the previous 2 weeks, associated with dry cough, sore throat, and diarrhea. He denied fever, chills, chest pain, abdominal pain, nausea, or vomiting. He did not have any sick contacts or travel history outside of Michigan. His medical history included hypertension, diabetes mellitus, chronic kidney disease, morbid obesity, paroxysmal atrial fibrillation, and tobacco use. He was taking amiodarone, carvedilol, furosemide, pregabalin, and insulin. The patient appeared to be in mild respiratory distress. He was afebrile and had saturation at 93% on 3 L of oxygen, heart rate of 105 beats/min, BP of 145/99 mm Hg, and respiratory rate of 18 breaths/min. On auscultation, there were crackles on bilateral lung bases and chronic bilateral leg swelling with hyperpigmented changes. His WBC count was 6.0 K/cumm (3.5 to 10.6 K/cumm) with absolute lymphocyte count 0.7 K/cumm (1.0 to 3.8 K/cumm); serum creatinine was 2.81 mg/dL (0.7 to 1.3 mg/dL). He had elevated inflammatory markers (serum ferritin, C-reactive protein, lactate dehydrogenase, D-dimer, and creatinine phosphokinase). Chest radiography showed bilateral pulmonary opacities that were suggestive of multifocal pneumonia (Fig 1). Nasopharyngeal swab for SARS-CoV-2 was positive. Therapy was started with ceftriaxone, doxycycline, hydroxychloroquine, and methylprednisolone 1 mg/kg IV for 3 days. By day 3 of hospitalization, he required endotracheal intubation, vasopressor support, and continuous renal replacement. Blood cultures were negative; respiratory cultures revealed only normal oral flora, so antibiotic therapy was discontinued. On day 10, WBC count increased to 28 K/cumm, and chest radiography showed persistent bilateral opacities with left lower lobe consolidation. Repeat respiratory cultures grew Pseudomonas aeruginosa (Table 1). Antibiotic therapy with IV meropenem was started. His condition steadily improved; eventually by day 20, he was off vasopressors and was extubated. However, on day 23, he experienced significant hemoptysis that required reintubation and vasopressor support.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Pasula S, Chandrasekar P. Spontaneous Hemoptysis in a Patient With COVID-19. Chest. 2021. PMID: 34246387. doi:10.1016/j.chest.2021.01.069

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。